Last updated on 12 Jul 2022
Owner Info
Elixirgen Therapeutics, Inc.
855 N. Wolfe St. Suite 624
Baltimore, MD, 21205 UNITED STATES OF AMERICA,
Serial Number
2232615 filed on 1 Dec 2021
Correspondent
Spruson & Ferguson
GPO Box 3898,
Sydney, NSW, 2001 AUSTRALIA,
2232615
1 Dec 2021
1 Dec 2031
WORD
Status Date | Action Taken |
---|---|
12th Jul 2022 | Status change to Registered/Protected |
12th Jul 2022 | Owner name details updated |
11th Jul 2022 | IP Right Registered correspondence sent |
2th May 2022 | Application Accepted correspondence sent |
2th May 2022 | IP Right has been Examined |
2th May 2022 | IP Right Acceptance Published |
11th Feb 2022 | Early Acceptance Notice correspondence sent |
11th Feb 2022 | Status change to Accepted |
6th Dec 2021 | Awaiting examination |
6th Dec 2021 | Word and image indexing completed |